Psychedelics

San Antonio researchers are investigating whether a drug better known as ecstasy can help people recover from post-traumatic stress disorder when combined with established psychotherapy.

Around 17% of service members who deploy to combat zones come home with PTSD — and for many, the road to recovery is long, difficult, and often out of reach. A new study hopes to change that by pairing a single dose of MDMA — known colloquially as ecstasy — with intensive therapy, potentially compressing recovery into just two weeks.

Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.

The largest psychedelic church in America has signed up more than 135,000 members who donate various amounts of money entitling them to corresponding amounts of psychedelics.

A new study finds that a single dose of LSD can ease a person's anxiety for months. This could give legitimacy to research on a range of psychedelics.

Research shows that psychedelics can help with a range of mental health conditions, like PTSD and depression. So why can't you get them from your doctor? Today on The Sunday Story, we take a trip through some of the latest science behind psychedelic therapy, and efforts to bring these mind‑altering drugs into the mainstream. Plus, what's ketamine got to do with it?

In a special Texas Public Radio podcast series medical reporter Bonnie Petrie and reporter Robin Berghaus explore how Texas is, somewhat ironically, leading the way in the therapeutic application of psychedelics.

The initiative signed into law by Gov. Greg Abbott will provide up to $50 million for clinical trials of the psychoactive substance ibogaine.

The Texas governor signed a $50 million bill into law on Wednesday to help bring ibogaine through FDA-approved clinical trials for opioid use disorders and other neurological and mental health conditions. Advocates said the legislation is the largest state-funded psychedelic research initiative in history.

In a special Texas Public Radio podcast series medical reporter Bonnie Petrie and reporter Robin Berghaus explore how Texas is, somewhat ironically, leading the way in the therapeutic application of psychedelics.